ReviewMicroorganisms2021
Cyclosporiasis-Updates on Clinical Presentation, Pathology, Clinical Diagnosis, and Treatment.
Review in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 41 citations in OpenAlex.
- Multi-Laboratory Evaluation of Modified BAM Chapter 19b and Long-Term Detection ofMicroorganisms · 2026Article
- Clinical and epidemiological characteristics of travel-associated cyclosporiasis in Santiago, Chile: Descriptive analysis over 5 years.New microbes and new infections · 2026Article
- First molecular detection and characterization ofIDCases · 2026Article
- ChronicASM case reports · 2025Article
- Assessing the sequencing success and analytical specificity of a targeted amplicon deep sequencing workflow for genotyping the foodborne parasiteJournal of clinical microbiology · 2025Article
- Shedding new light onJournal of clinical microbiology · 2025Article
- Prevalence and Associated Risk Factors ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025Review
- Zero-Valent Iron and Sand Filtration Reduces Levels ofMicroorganisms · 2024Article
- Molecular Identification and Survey ofAnimals : an open access journal from MDPI · 2024Article
- Evaluation of the Increased Genetic Resolution and Utility for Source Tracking of a Recently Developed Method for GenotypingMicroorganisms · 2024Article
- Editorial for the Special IssueMicroorganisms · 2024Article
- Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.PLoS neglected tropical diseases · 2023Article
- Development and Evaluation/Verification of a Fully Automated Test Platform for the Rapid Detection ofMicroorganisms · 2023Article
- Article
- Article
- Novel insights on the genetic population structure of human-infectingCurrent research in parasitology & vector-borne diseases · 2023Article
- Development of a targeted amplicon sequencing method for genotypingFrontiers in microbiology · 2023Article
- Transmission electron microscopy on a case ofParasitology · 2022Article
- The Clinical Features and Immunological Signature ofMicroorganisms · 2022Article
- Life Cycle and Transmission ofMicroorganisms · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.